STRATEC SE

Share Issue/Capital Change • Aug 25, 2015

News Details

Other Capital Market Information | 25 August 2015 15:21

STRATEC Biomedical AG: Release according to Article 30e of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG / Law amendment of securities according to § 30e Para. 1, No. 1 of the WpHG [the German Securities Trading Act]

25.08.2015 15:21

Dissemination of a Post-admission Duties announcement according to Article 30e Para. 1, No. 1 WpHG, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---

STRATEC Biomedical AG, Birkenfeld

Announcement of Conversion from Bearer Par-Value Shares into Registered
No-Par Value Shares

• ISIN (old): DE0007289001 / German SIN (old): 728900 -
• ISIN (new): DE000STRA555 / German SIN (new): STRA55 -

At the annual general meeting of STRATEC Biomedical AG held on May 22, 2015
a resolution was adopted concerning the conversion from bearer par-value
shares into registered no-par-value shares and the amendments to the
articles of incorporation necessary in this respect.

Following registration of the amendments to the articles of incorporation
in the company's entry in the Commercial Register at Mannheim Local Court
(registration no. HRB 504390), the company's share capital of EUR
11,846,595.00 is now divided into 11,846,595 registered no-par value shares
(shares without a nominal amount), each representing a notional stake of
EUR 1.00 in the share capital.

The conversion into registered no-par value shares will be effected for
securities account/stock market purposes on August 28, 2015, after the
stock market closes. To this end the bearer par-value shares of STRATEC
Biomedical AG with the old ISIN DE0007289001 that are held in custody by
banks will be converted 1:1 to registered no-par value shares of STRATEC
Biomedical AG with the new ISIN DE000STRA555. The stock exchange listing
will be changed over at the same time. Open orders that have not yet been
processed on August 28, 2015 will be cancelled as a result of the
conversion.

The conversion to registered shares will be executed on August 28, 2015
after the close of stock market trading.

As of August 31, 2015 the shares of STRATEC Biomedical AG will be listed on
the Prime Standard segment of the regulated market at Frankfurt Stock
Exchange as registered no-par value shares of STRATEC Biomedical AG. From
that day on the only STRATEC Biomedical AG shares that can be traded are
the registered no-par value shares with the new ISIN DE000STRA555.

The registered no-par value shares in STRATEC Biomedical AG are represented
by a global note that is deposited with Clearstream Banking AG in Frankfurt
am Main. The company's shareholders will all be co-owners - in proportion
to the size of their shares - of the collective securities deposit at
Clearstream Banking AG.

The conversion into registered no-par value shares means that the company
needs to keep a share register listing all the shareholders with - for
natural persons - name, address and date of birth, and - for legal entities
- company name, business address and registered office, and, in both cases,
the number of shares held. The entry of shareholders acting in their own
name in the share register for shares belonging to another person will only
be permitted and valid vis-à-vis the Company if the fact that the shares
belong to another person as well as the name and address of the owner have
been entered in the share register. The same also applies should the
persons entered in the share register or the owners transfer their
ownership of the shares to another person after entry in the share
register. Listing in the share register is important for individual
shareholders, it being a prerequisite for participation in, and voting at,
general meetings because only those identified in the list are actually
deemed shareholders of the company.

The legal status of shareholders listed in the share register is not
affected by the conversion from bearer par-value shares into registered
no-par value shares; their stake in the company remains unchanged, as do
the rights conferred by their shares. Nor does the conversion restrict or
impede the right of shareholders to sell their shares because they do not
require STRATEC Biomedical AG's consent in order to transfer registered
no-par value shares.

Landesbank Baden-Württemberg, Stuttgart has been charged with handling the
technical details of the conversion in terms of banking and securities
regulations.

The conversion of securities deposits from bearer par-value shares into
registered no-par value shares is made at no cost to the shareholders of
STRATEC Biomedical AG.

Birkenfeld, August 2015

STRATEC Biomedical AG

The Management Board

25.08.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com

End of Announcement DGAP News-Service

---